Targeting Chemotherapy-Induced Adaptive Signaling Circuitry for Therapeutic Potential in Pancreatic Cancer Background Introduction Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal cancer, with a five-year survival rate that remains extremely low. Over 80% of patients are diagnosed at an advanced, unresectable stage, where existin...